{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T17:49:56Z","timestamp":1788544196382,"version":"build-2803163510"},"reference-count":137,"publisher":"Elsevier BV","issue":"20","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T00:00:00Z","timestamp":1729123200000},"content-version":"vor","delay-in-days":16,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000143","name":"Alzheimer Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000143","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000156","name":"Fonds de Recherche du Qu\u00e9bec - Sant\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.heliyon.2024.e39571","type":"journal-article","created":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T15:02:19Z","timestamp":1729263739000},"page":"e39571","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Pharmacological inhibition of PLK2 kinase activity mitigates cognitive decline but aggravates APP pathology in a sex-dependent manner in APP\/PS1 mouse model of Alzheimer's disease"],"prefix":"10.1016","volume":"10","author":[{"given":"Laura","family":"Mart\u00ednez-Drudis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan","family":"B\u00e9rard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dylan","family":"Musiol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge","family":"Rivest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1122-7086","authenticated-orcid":false,"given":"Abid","family":"Oueslati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10284","key":"10.1016\/j.heliyon.2024.e39571_bib1","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","article-title":"Alzheimer's disease","volume":"397","author":"Scheltens","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.heliyon.2024.e39571_bib2","series-title":"World Alzheimer Report 2023: Reducing Dementia Risk: Never Too Early, Never Too Late","author":"Long","year":"2023"},{"issue":"10","key":"10.1016\/j.heliyon.2024.e39571_bib3","doi-asserted-by":"crossref","first-page":"5481","DOI":"10.1038\/s41380-021-01249-0","article-title":"The amyloid-beta pathway in Alzheimer's disease","volume":"26","author":"Hampel","year":"2021","journal-title":"Mol. Psychiatr."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e39571_bib4","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA Research Framework: toward a biological definition of Alzheimer's disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement"},{"issue":"10","key":"10.1016\/j.heliyon.2024.e39571_bib5","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0165-6147(91)90609-V","article-title":"Amyloid deposition as the central event in the aetiology of Alzheimer's disease","volume":"12","author":"Hardy","year":"1991","journal-title":"Trends Pharmacol. Sci."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e39571_bib6","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.cell.2019.09.001","article-title":"Alzheimer disease: an update on pathobiology and treatment strategies","volume":"179","author":"Long","year":"2019","journal-title":"Cell"},{"issue":"6106","key":"10.1016\/j.heliyon.2024.e39571_bib7","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/325733a0","article-title":"The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor","volume":"325","author":"Kang","year":"1987","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e39571_bib8","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/0896-6273(91)90052-2","article-title":"The molecular pathology of Alzheimer's disease","volume":"6","author":"Selkoe","year":"1991","journal-title":"Neuron"},{"key":"10.1016\/j.heliyon.2024.e39571_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.695808","article-title":"APP, PSEN1, and PSEN2 variants in Alzheimer's disease: systematic Re-evaluation according to ACMG guidelines","volume":"13","author":"Xiao","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.heliyon.2024.e39571_bib10","doi-asserted-by":"crossref","first-page":"535","DOI":"10.2147\/CIA.S51571","article-title":"The genetics of Alzheimer's disease","volume":"9","author":"Bagyinszky","year":"2014","journal-title":"Clin. Interv. Aging"},{"issue":"5","key":"10.1016\/j.heliyon.2024.e39571_bib11","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/ng0892-345","article-title":"A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of beta-amyloid","volume":"1","author":"Mullan","year":"1992","journal-title":"Nat. Genet."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e39571_bib12","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/nm0498-452","article-title":"A variant of Alzheimer's disease with spastic paraparesis and unusual plaques due to deletion of exon 9 of presenilin 1","volume":"4","author":"Crook","year":"1998","journal-title":"Nat. Med."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e39571_bib13","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.jalz.2016.01.012","article-title":"Molecular genetics of early-onset Alzheimer's disease revisited","volume":"12","author":"Cacace","year":"2016","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.heliyon.2024.e39571_bib14","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3389\/fgene.2014.00088","article-title":"Using mice to model Alzheimer's dementia: an overview of the clinical disease and the preclinical behavioral changes in 10 mouse models","volume":"5","author":"Webster","year":"2014","journal-title":"Front. Genet."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e39571_bib15","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.3233\/JAD-170045","article-title":"Mouse models of Alzheimer's disease","volume":"57","author":"Esquerda-Canals","year":"2017","journal-title":"J. Alzheimers Dis."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e39571_bib16","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.pharmthera.2013.12.009","article-title":"Genetic mouse models of brain ageing and Alzheimer's disease","volume":"142","author":"Bilkei-Gorzo","year":"2014","journal-title":"Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e39571_bib17","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s40478-022-01417-5","article-title":"Modeling the early stages of Alzheimer's disease by administering intracerebroventricular injections of human native Abeta oligomers to rats","volume":"10","author":"Baerends","year":"2022","journal-title":"Acta Neuropathol. Commun."},{"issue":"12","key":"10.1016\/j.heliyon.2024.e39571_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0242989","article-title":"Neurotoxicity of different amyloid beta subspecies in mice and their interaction with isoflurane anaesthesia","volume":"15","author":"Borgstedt","year":"2020","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.heliyon.2024.e39571_bib19","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1517\/17460441.2015.1041913","article-title":"Rodent models for Alzheimer's disease drug discovery","volume":"10","author":"Puzzo","year":"2015","journal-title":"Expet Opin. Drug Discov."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e39571_bib20","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00401-016-1662-x","article-title":"Alzheimer's disease: experimental models and reality","volume":"133","author":"Drummond","year":"2017","journal-title":"Acta Neuropathol."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e39571_bib21","doi-asserted-by":"crossref","first-page":"953","DOI":"10.3233\/JAD-170176","article-title":"Protein phosphorylation is a key mechanism in Alzheimer's disease","volume":"58","author":"Oliveira","year":"2017","journal-title":"J. Alzheimers Dis."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e39571_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21010209","article-title":"Phosphorylation signaling in APP processing in Alzheimer's disease","volume":"21","author":"Zhang","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.heliyon.2024.e39571_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2022.105833","article-title":"Inhibition of PLK2 activity affects APP and tau pathology and improves synaptic content in a sex-dependent manner in a 3xTg mouse model of Alzheimer's disease","volume":"172","author":"Martinez-Drudis","year":"2022","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.heliyon.2024.e39571_bib24","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.neuropharm.2017.02.027","article-title":"Polo-like kinase 2 phosphorylation of amyloid precursor protein regulates activity-dependent amyloidogenic processing","volume":"117","author":"Lee","year":"2017","journal-title":"Neuropharmacology"},{"issue":"7","key":"10.1016\/j.heliyon.2024.e39571_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0219691","article-title":"Inhibition of Polo-like kinase 2 ameliorates pathogenesis in Alzheimer's disease model mice","volume":"14","author":"Lee","year":"2019","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e39571_bib26","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1074\/jbc.M109.081950","article-title":"Phosphorylation of synucleins by members of the Polo-like kinase family","volume":"285","author":"Mbefo","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e39571_bib27","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0197-4580(00)00218-9","article-title":"Neuronal polo-like kinase in Alzheimer disease indicates cell cycle changes","volume":"21","author":"Harris","year":"2000","journal-title":"Neurobiol. Aging"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e39571_bib28","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/WAD.0000000000000002","article-title":"Reelin signaling pathway genotypes and Alzheimer disease in a Spanish population","volume":"29","author":"Bufill","year":"2015","journal-title":"Alzheimer Dis. Assoc. Disord."},{"issue":"8","key":"10.1016\/j.heliyon.2024.e39571_bib29","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.neurobiolaging.2003.08.012","article-title":"Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease","volume":"24","author":"Oddo","year":"2003","journal-title":"Neurobiol. Aging"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e39571_bib30","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0896-6273(03)00434-3","article-title":"Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction","volume":"39","author":"Oddo","year":"2003","journal-title":"Neuron"},{"issue":"5","key":"10.1016\/j.heliyon.2024.e39571_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1008155","article-title":"Enhancing face validity of mouse models of Alzheimer's disease with natural genetic variation","volume":"15","author":"Onos","year":"2019","journal-title":"PLoS Genet."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e39571_bib32","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.neuron.2018.11.040","article-title":"Harnessing genetic complexity to enhance translatability of Alzheimer's disease mouse models: a path toward precision medicine","volume":"101","author":"Neuner","year":"2019","journal-title":"Neuron"},{"issue":"5","key":"10.1016\/j.heliyon.2024.e39571_bib33","doi-asserted-by":"crossref","first-page":"465","DOI":"10.2174\/156720506779025198","article-title":"Genetic and environmental modifiers of Alzheimer's disease phenotypes in the mouse","volume":"3","author":"Ryman","year":"2006","journal-title":"Curr. Alzheimer Res."},{"issue":"22","key":"10.1016\/j.heliyon.2024.e39571_bib34","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1093\/hmg\/ddg322","article-title":"Genetic background regulates beta-amyloid precursor protein processing and beta-amyloid deposition in the mouse","volume":"12","author":"Lehman","year":"2003","journal-title":"Hum. Mol. Genet."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e39571_bib35","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/msj.20159","article-title":"Transgenic mouse models of Alzheimer's disease","volume":"77","author":"Elder","year":"2010","journal-title":"Mt. Sinai J. Med."},{"key":"10.1016\/j.heliyon.2024.e39571_bib36","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2022.912995","article-title":"Mouse models of Alzheimer's disease","volume":"15","author":"Yokoyama","year":"2022","journal-title":"Front. Mol. Neurosci."},{"issue":"10","key":"10.1016\/j.heliyon.2024.e39571_bib37","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23105404","article-title":"Transgenic mouse models of Alzheimer's disease: an integrative analysis","volume":"23","author":"Sanchez-Varo","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.heliyon.2024.e39571_bib38","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/nan.12440","article-title":"Review: neuropathology and behavioural features of transgenic murine models of Alzheimer's disease","volume":"43","author":"Ameen-Ali","year":"2017","journal-title":"Neuropathol. Appl. Neurobiol."},{"issue":"9","key":"10.1016\/j.heliyon.2024.e39571_bib39","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1016\/j.bmcl.2013.02.065","article-title":"Design and synthesis of highly selective, orally active Polo-like kinase-2 (Plk-2) inhibitors","volume":"23","author":"Bowers","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.heliyon.2024.e39571_bib40","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.nbd.2017.06.014","article-title":"Polo-like kinase 2 modulates alpha-synuclein protein levels by regulating its mRNA production","volume":"106","author":"Kofoed","year":"2017","journal-title":"Neurobiol. Dis."},{"issue":"10","key":"10.1016\/j.heliyon.2024.e39571_bib41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0252635","article-title":"Polo-like kinase 2 inhibition reduces serine-129 phosphorylation of physiological nuclear alpha-synuclein but not of the aggregated alpha-synuclein","volume":"16","author":"Elfarrash","year":"2021","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.heliyon.2024.e39571_bib42","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1389-0344(01)00067-3","article-title":"Co-expression of multiple transgenes in mouse CNS: a comparison of strategies","volume":"17","author":"Jankowsky","year":"2001","journal-title":"Biomol. Eng."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e39571_bib43","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.nbd.2006.08.017","article-title":"Characterization of amyloid deposition in the APPswe\/PS1dE9 mouse model of Alzheimer disease","volume":"24","author":"Garcia-Alloza","year":"2006","journal-title":"Neurobiol. Dis."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e39571_bib44","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/nprot.2007.44","article-title":"The use of the elevated plus maze as an assay of anxiety-related behavior in rodents","volume":"2","author":"Walf","year":"2007","journal-title":"Nat. Protoc."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e39571_bib45","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/BF00177912","article-title":"The use of a plus-maze to measure anxiety in the mouse","volume":"92","author":"Lister","year":"1987","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.heliyon.2024.e39571_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.104951","article-title":"Use of adeno-associated virus-mediated delivery of mutant huntingtin to study the spreading capacity of the protein in mice and non-human primates","volume":"141","author":"Maxan","year":"2020","journal-title":"Neurobiol. Dis."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e39571_bib47","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0006-8993(98)01258-X","article-title":"Behavioral phenotyping of transgenic and knockout mice: experimental design and evaluation of general health, sensory functions, motor abilities, and specific behavioral tests","volume":"835","author":"Crawley","year":"1999","journal-title":"Brain Res."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e39571_bib48","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1037\/0033-2909.83.3.482","article-title":"The Open-Field Test: a critical review","volume":"83","author":"Walsh","year":"1976","journal-title":"Psychol. Bull."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e39571_bib49","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.nlm.2009.02.002","article-title":"Intrasession and intersession habituation in mice: from inbred strain variability to linkage analysis","volume":"92","author":"Bolivar","year":"2009","journal-title":"Neurobiol. Learn. Mem."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e39571_bib50","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0149-7634(01)00041-0","article-title":"The neurobiological basis of spontaneous alternation","volume":"26","author":"Lalonde","year":"2002","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.heliyon.2024.e39571_bib51","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/978-1-4939-8994-2_10","article-title":"The Y-maze for assessment of spatial working and reference memory in mice","volume":"1916","author":"Kraeuter","year":"2019","journal-title":"Methods Mol. Biol."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e39571_bib52","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1016\/j.ymthe.2022.01.020","article-title":"Passive immunization against phosphorylated tau improves features of Huntington's disease pathology","volume":"30","author":"Alpaugh","year":"2022","journal-title":"Mol. Ther."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e39571_bib53","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/nprot.2006.116","article-title":"Morris water maze: procedures for assessing spatial and related forms of learning and memory","volume":"1","author":"Vorhees","year":"2006","journal-title":"Nat. Protoc."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e39571_bib54","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/0023-9690(81)90020-5","article-title":"Spatial localization does not require the presence of local cues","volume":"12","author":"Morris","year":"1981","journal-title":"Learn. Motiv."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e39571_bib55","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0165-0270(84)90007-4","article-title":"Developments of a water-maze procedure for studying spatial learning in the rat","volume":"11","author":"Morris","year":"1984","journal-title":"J. Neurosci. Methods"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e39571_bib56","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s13024-023-00683-8","article-title":"Non-invasive systemic viral delivery of human alpha-synuclein mimics selective and progressive neuropathology of Parkinson's disease in rodent brains","volume":"18","author":"Berard","year":"2023","journal-title":"Mol. Neurodegener."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e39571_bib57","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1601-183X.2004.00071.x","article-title":"Automated apparatus for quantitation of social approach behaviors in mice","volume":"3","author":"Nadler","year":"2004","journal-title":"Gene Brain Behav."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e39571_bib58","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1601-1848.2004.00076.x","article-title":"Sociability and preference for social novelty in five inbred strains: an approach to assess autistic-like behavior in mice","volume":"3","author":"Moy","year":"2004","journal-title":"Gene Brain Behav."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e39571_bib59","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/j.1750-3639.2007.00096.x","article-title":"Mouse behavioral assays relevant to the symptoms of autism","volume":"17","author":"Crawley","year":"2007","journal-title":"Brain Pathol."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e39571_bib60","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1006\/exnr.2001.7754","article-title":"Time course of the development of Alzheimer-like pathology in the doubly transgenic PS1+APP mouse","volume":"173","author":"Gordon","year":"2002","journal-title":"Exp. Neurol."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e39571_bib61","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1074\/jbc.C800206200","article-title":"Polo-like kinase 2 (PLK2) phosphorylates alpha-synuclein at serine 129 in central nervous system","volume":"284","author":"Inglis","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"41","key":"10.1016\/j.heliyon.2024.e39571_bib62","doi-asserted-by":"crossref","first-page":"E3945","DOI":"10.1073\/pnas.1309991110","article-title":"Polo-like kinase 2 regulates selective autophagic alpha-synuclein clearance and suppresses its toxicity in vivo","volume":"110","author":"Oueslati","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"41","key":"10.1016\/j.heliyon.2024.e39571_bib63","doi-asserted-by":"crossref","first-page":"16293","DOI":"10.1073\/pnas.1315622110","article-title":"Silencing synuclein at the synapse with PLK2","volume":"110","author":"Looyenga","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"9","key":"10.1016\/j.heliyon.2024.e39571_bib64","doi-asserted-by":"crossref","first-page":"3919","DOI":"10.1074\/jbc.M116.759373","article-title":"Dissecting the molecular pathway involved in PLK2 kinase-mediated alpha-Synuclein-selective autophagic degradation","volume":"292","author":"Dahmene","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.heliyon.2024.e39571_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.100273","article-title":"Genetic deletion of Polo-like kinase 2 reduces alpha-synuclein serine-129 phosphorylation in presynaptic terminals but not Lewy bodies","volume":"296","author":"Weston","year":"2021","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e39571_bib66","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41531-023-00444-w","article-title":"Dynamic physiological alpha-synuclein S129 phosphorylation is driven by neuronal activity","volume":"9","author":"Ramalingam","year":"2023","journal-title":"NPJ Parkinsons Dis"},{"issue":"96","key":"10.1016\/j.heliyon.2024.e39571_bib67","doi-asserted-by":"crossref","DOI":"10.3791\/52434-v","article-title":"Use of the Open Field Maze to measure locomotor and anxiety-like behavior in mice","author":"Seibenhener","year":"2015","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.heliyon.2024.e39571_bib68","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1750-1326-7-28","article-title":"Transgenic APP expression during postnatal development causes persistent locomotor hyperactivity in the adult","volume":"7","author":"Rodgers","year":"2012","journal-title":"Mol. Neurodegener."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e39571_bib69","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s11357-016-9929-7","article-title":"Characterization of AD-like phenotype in aged APPSwe\/PS1dE9 mice","volume":"38","author":"Huang","year":"2016","journal-title":"Age (Dordr)"},{"key":"10.1016\/j.heliyon.2024.e39571_bib70","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.neurobiolaging.2021.12.009","article-title":"Both male and female APPswe\/PSEN1dE9 mice are impaired in spatial memory and cognitive flexibility at 9 months of age","volume":"113","author":"Hulshof","year":"2022","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.heliyon.2024.e39571_bib71","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.772980","article-title":"Deficits in N-Methyl-D-Aspartate receptor function and synaptic plasticity in hippocampal CA1 in APP\/PS1 mouse model of Alzheimer's disease","volume":"13","author":"Xu","year":"2021","journal-title":"Front. Aging Neurosci."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e39571_bib72","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0063643","article-title":"A longitudinal study of cognition, proton MR spectroscopy and synaptic and neuronal pathology in aging wild-type and AbetaPPswe-PS1dE9 mice","volume":"8","author":"Jansen","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e39571_bib73","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s13195-017-0306-2","article-title":"Tracking progressive pathological and functional decline in the rTg4510 mouse model of tauopathy","volume":"9","author":"Blackmore","year":"2017","journal-title":"Alzheimer's Res. Ther."},{"issue":"11","key":"10.1016\/j.heliyon.2024.e39571_bib74","doi-asserted-by":"crossref","first-page":"3592","DOI":"10.1016\/j.celrep.2019.11.044","article-title":"Amyloid beta and tau cooperate to cause reversible behavioral and transcriptional deficits in a model of Alzheimer's disease","volume":"29","author":"Pickett","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.heliyon.2024.e39571_bib75","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.cortex.2020.08.001","article-title":"Cognitive and behavioural inhibition deficits in neurodegenerative dementias","volume":"131","author":"Migliaccio","year":"2020","journal-title":"Cortex"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e39571_bib76","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1017\/S1355617719000973","article-title":"Disinhibition in frontotemporal dementia and Alzheimer's disease: a neuropsychological and behavioural investigation","volume":"26","author":"Mariano","year":"2020","journal-title":"J. Int. Neuropsychol. Soc."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e39571_bib77","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1037\/0735-7044.121.2.340","article-title":"Increase of locomotor activity underlying the behavioral disinhibition in tg2576 mice","volume":"121","author":"Gil-Bea","year":"2007","journal-title":"Behav. Neurosci."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e39571_bib78","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.neulet.2004.07.069","article-title":"Exploratory activity, anxiety, and motor coordination in bigenic APPswe + PS1\/DeltaE9 mice","volume":"369","author":"Lalonde","year":"2004","journal-title":"Neurosci. Lett."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e39571_bib79","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1601-183X.2006.00221.x","article-title":"Impaired spatial learning in the APPSwe + PSEN1DeltaE9 bigenic mouse model of Alzheimer's disease","volume":"6","author":"Reiserer","year":"2007","journal-title":"Gene Brain Behav."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e39571_bib80","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1159\/000337458","article-title":"Impaired performance of female APP\/PS1 mice in the Morris water maze is coupled with increased Abeta accumulation and microglial activation","volume":"11","author":"Gallagher","year":"2013","journal-title":"Neurodegener. Dis."},{"key":"10.1016\/j.heliyon.2024.e39571_bib81","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.bbi.2020.10.021","article-title":"Analysis of CX3CR1 haplodeficiency in male and female APP(swe)\/PSEN1(dE9) mice along Alzheimer disease progression","volume":"91","author":"Hemonnot-Girard","year":"2021","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.heliyon.2024.e39571_bib82","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/978-1-0716-0592-9_19","article-title":"Staining and quantification of beta-amyloid pathology in transgenic mouse models of Alzheimer's disease","volume":"2144","author":"Christensen","year":"2020","journal-title":"Methods Mol. Biol."},{"issue":"34","key":"10.1016\/j.heliyon.2024.e39571_bib83","doi-asserted-by":"crossref","first-page":"10706","DOI":"10.1523\/JNEUROSCI.2637-09.2009","article-title":"Characterizing the appearance and growth of amyloid plaques in APP\/PS1 mice","volume":"29","author":"Yan","year":"2009","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e39571_bib84","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/hmg\/ddh019","article-title":"Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase","volume":"13","author":"Jankowsky","year":"2004","journal-title":"Hum. Mol. Genet."},{"issue":"12","key":"10.1016\/j.heliyon.2024.e39571_bib85","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1038\/nm1485","article-title":"Activation of beta2-adrenergic receptor stimulates gamma-secretase activity and accelerates amyloid plaque formation","volume":"12","author":"Ni","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.heliyon.2024.e39571_bib86","article-title":"Multifocal cerebral microinfarcts modulate early Alzheimer's disease pathology in a sex-dependent manner","volume":"12","author":"Lecordier","year":"2021","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e39571_bib87","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0896-6273(94)90458-8","article-title":"Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals: evidence that an initially deposited species is A beta 42(43)","volume":"13","author":"Iwatsubo","year":"1994","journal-title":"Neuron"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e39571_bib88","doi-asserted-by":"crossref","first-page":"787","DOI":"10.3233\/JAD-142208","article-title":"Systematic review of the relationship between amyloid-beta levels and measures of transgenic mouse cognitive deficit in Alzheimer's disease","volume":"44","author":"Foley","year":"2015","journal-title":"J. Alzheimers Dis."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e39571_bib89","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1093\/jnen\/nlw109","article-title":"Association of neuropathological markers in the parietal cortex with antemortem cognitive function in persons with mild cognitive impairment and Alzheimer disease","volume":"76","author":"Tremblay","year":"2017","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e39571_bib90","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1038\/s41598-017-02841-7","article-title":"C-terminal fragments of the amyloid precursor protein in cerebrospinal fluid as potential biomarkers for Alzheimer disease","volume":"7","author":"Garcia-Ayllon","year":"2017","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e39571_bib91","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41420-021-00796-3","article-title":"Accumulation of APP-CTF induces mitophagy dysfunction in the iNSCs model of Alzheimer's disease","volume":"8","author":"Lee","year":"2022","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e39571_bib92","doi-asserted-by":"crossref","first-page":"6555","DOI":"10.1038\/s41598-019-43076-y","article-title":"Synapse loss and progress of Alzheimer's disease -A network model","volume":"9","author":"Kashyap","year":"2019","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e39571_bib93","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.molmed.2005.02.009","article-title":"Alzheimer's disease: abeta, tau and synaptic dysfunction","volume":"11","author":"LaFerla","year":"2005","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.heliyon.2024.e39571_bib94","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.arr.2014.09.004","article-title":"A framework to understand the variations of PSD-95 expression in brain aging and in Alzheimer's disease","volume":"18","author":"Savioz","year":"2014","journal-title":"Ageing Res. Rev."},{"issue":"8","key":"10.1016\/j.heliyon.2024.e39571_bib95","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1097\/00005072-199708000-00011","article-title":"Loss of the presynaptic vesicle protein synaptophysin in hippocampus correlates with cognitive decline in Alzheimer disease","volume":"56","author":"Sze","year":"1997","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e39571_bib96","doi-asserted-by":"crossref","first-page":"377","DOI":"10.3233\/JAD-2007-12411","article-title":"Biochemical characterization of Abeta and tau pathologies in mild cognitive impairment and Alzheimer's disease","volume":"12","author":"Tremblay","year":"2007","journal-title":"J. Alzheimers Dis."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e39571_bib97","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1212\/WNL.56.1.127","article-title":"Altered expression of synaptic proteins occurs early during progression of Alzheimer's disease","volume":"56","author":"Masliah","year":"2001","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.heliyon.2024.e39571_bib98","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1097\/00005072-199906000-00008","article-title":"Loss of proteins regulating synaptic plasticity in normal aging of the human brain and in Alzheimer disease","volume":"58","author":"Hatanpaa","year":"1999","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e39571_bib99","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3233\/JAD-2005-7203","article-title":"Differential loss of synaptic proteins in Alzheimer's disease: implications for synaptic dysfunction","volume":"7","author":"Reddy","year":"2005","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.heliyon.2024.e39571_bib100","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/978-4-431-56550-5_12","article-title":"Drebrin in Alzheimer's disease","volume":"1006","author":"Ishizuka","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.heliyon.2024.e39571_bib101","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115817","article-title":"Targeting protein kinases for the treatment of Alzheimer's disease: recent progress and future perspectives","volume":"261","author":"Li","year":"2023","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e39571_bib102","article-title":"Targeting dementias through cancer kinases inhibition","volume":"6","author":"Fagiani","year":"2020","journal-title":"Alzheimers Dement (N Y)"},{"key":"10.1016\/j.heliyon.2024.e39571_bib103","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/978-3-030-49844-3_11","article-title":"Alzheimer's disease and protein kinases","volume":"1275","author":"Engin","year":"2021","journal-title":"Adv. Exp. Med. Biol."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e39571_bib104","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0125897","article-title":"DBA\/2J genetic background exacerbates spontaneous lethal seizures but lessens amyloid deposition in a mouse model of Alzheimer's disease","volume":"10","author":"Jackson","year":"2015","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.heliyon.2024.e39571_bib105","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1016\/j.neurobiolaging.2007.02.017","article-title":"Genetic loci modulating amyloid-beta levels in a mouse model of Alzheimer's disease","volume":"29","author":"Ryman","year":"2008","journal-title":"Neurobiol. Aging"},{"issue":"5","key":"10.1016\/j.heliyon.2024.e39571_bib106","first-page":"1480","article-title":"Characterization of the inbred CE\/J mouse strain as amyloid resistant","volume":"143","author":"Sipe","year":"1993","journal-title":"Am. J. Pathol."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e39571_bib107","doi-asserted-by":"crossref","first-page":"135","DOI":"10.15761\/JSIN.1000123","article-title":"Effect of mouse strain as a background for Alzheimer's disease models on the clearance of amyloid-beta","volume":"2","author":"Qosa","year":"2016","journal-title":"J. Syst. Integr. Neurosci."},{"key":"10.1016\/j.heliyon.2024.e39571_bib108","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.neuropharm.2014.01.023","article-title":"Differences in amyloid-beta clearance across mouse and human blood-brain barrier models: kinetic analysis and mechanistic modeling","volume":"79","author":"Qosa","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.heliyon.2024.e39571_bib109","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.semcdb.2022.05.028","article-title":"Synapse pathology in Alzheimer's disease","volume":"139","author":"Griffiths","year":"2023","journal-title":"Semin. Cell Dev. Biol."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e39571_bib110","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/ana.410270502","article-title":"Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity","volume":"27","author":"DeKosky","year":"1990","journal-title":"Ann. Neurol."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e39571_bib111","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/ana.410300410","article-title":"Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment","volume":"30","author":"Terry","year":"1991","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.heliyon.2024.e39571_bib112","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainresbull.2015.12.003","article-title":"Toward more predictive genetic mouse models of Alzheimer's disease","volume":"122","author":"Onos","year":"2016","journal-title":"Brain Res. Bull."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e39571_bib113","doi-asserted-by":"crossref","first-page":"M117","DOI":"10.1093\/gerona\/52A.2.M117","article-title":"Heritability for Alzheimer's disease: the study of dementia in Swedish twins","volume":"52","author":"Gatz","year":"1997","journal-title":"J. Gerontol A Biol. Sci. Med. Sci."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e39571_bib114","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s13024-017-0231-7","article-title":"Practical considerations for choosing a mouse model of Alzheimer's disease","volume":"12","author":"Jankowsky","year":"2017","journal-title":"Mol. Neurodegener."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e39571_bib115","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.brainresbull.2011.11.017","article-title":"Mouse models of Alzheimer's disease","volume":"88","author":"Hall","year":"2012","journal-title":"Brain Res. Bull."},{"issue":"11","key":"10.1016\/j.heliyon.2024.e39571_bib116","doi-asserted-by":"crossref","first-page":"4907","DOI":"10.1007\/s00018-021-03830-w","article-title":"Alzheimer's pathogenic mechanisms and underlying sex difference","volume":"78","author":"Zhu","year":"2021","journal-title":"Cell. Mol. Life Sci."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e39571_bib117","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S1474-4422(16)00067-3","article-title":"Sex differences in Alzheimer's disease and other dementias","volume":"15","author":"Mazure","year":"2016","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.heliyon.2024.e39571_bib118","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.neurobiolaging.2018.04.004","article-title":"Sexual dimorphism in predisposition to Alzheimer's disease","volume":"70","author":"Fisher","year":"2018","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.heliyon.2024.e39571_bib119","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2147\/CLEP.S37929","article-title":"Clinical epidemiology of Alzheimer's disease: assessing sex and gender differences","volume":"6","author":"Mielke","year":"2014","journal-title":"Clin. Epidemiol."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e39571_bib120","doi-asserted-by":"crossref","first-page":"437","DOI":"10.31887\/DCNS.2016.18.4\/cepperson","article-title":"Considering sex and gender in Alzheimer disease and other dementias","volume":"18","author":"Podcasy","year":"2016","journal-title":"Dialogues Clin. Neurosci."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e39571_bib121","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.3233\/JAD-191183","article-title":"Sex differences in in vivo Alzheimer's disease neuropathology in late middle-aged Hispanics","volume":"74","author":"Luchsinger","year":"2020","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.heliyon.2024.e39571_bib122","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.neurobiolaging.2021.04.003","article-title":"Multimodal neuroimaging of sex differences in cognitively impaired patients on the Alzheimer's continuum: greater tau-PET retention in females","volume":"105","author":"Edwards","year":"2021","journal-title":"Neurobiol. Aging"},{"issue":"6","key":"10.1016\/j.heliyon.2024.e39571_bib123","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1007\/s00401-018-1920-1","article-title":"Sex differences in Alzheimer's disease and common neuropathologies of aging","volume":"136","author":"Oveisgharan","year":"2018","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.heliyon.2024.e39571_bib124","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2024.1346621","article-title":"A case for seeking sex-specific treatments in Alzheimer's disease","volume":"16","author":"Lynch","year":"2024","journal-title":"Front. Aging Neurosci."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e39571_bib125","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.neuron.2011.02.004","article-title":"Requirement for Plk2 in orchestrated ras and rap signaling, homeostatic structural plasticity, and memory","volume":"69","author":"Lee","year":"2011","journal-title":"Neuron"},{"issue":"42","key":"10.1016\/j.heliyon.2024.e39571_bib126","doi-asserted-by":"crossref","first-page":"16490","DOI":"10.1523\/JNEUROSCI.2131-13.2013","article-title":"Opposing action of nuclear factor kappaB and Polo-like kinases determines a homeostatic end point for excitatory synaptic adaptation","volume":"33","author":"Mihalas","year":"2013","journal-title":"J. Neurosci."},{"issue":"10","key":"10.1016\/j.heliyon.2024.e39571_bib127","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1038\/nn.2624","article-title":"Plk2 attachment to NSF induces homeostatic removal of GluA2 during chronic overexcitation","volume":"13","author":"Evers","year":"2010","journal-title":"Nat. Neurosci."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e39571_bib128","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.neuron.2008.03.021","article-title":"Critical role of CDK5 and Polo-like kinase 2 in homeostatic synaptic plasticity during elevated activity","volume":"58","author":"Seeburg","year":"2008","journal-title":"Neuron"},{"issue":"26","key":"10.1016\/j.heliyon.2024.e39571_bib129","doi-asserted-by":"crossref","first-page":"6583","DOI":"10.1523\/JNEUROSCI.1853-08.2008","article-title":"Activity-induced Polo-like kinase 2 is required for homeostatic plasticity of hippocampal neurons during epileptiform activity","volume":"28","author":"Seeburg","year":"2008","journal-title":"J. Neurosci."},{"issue":"43","key":"10.1016\/j.heliyon.2024.e39571_bib130","doi-asserted-by":"crossref","first-page":"29424","DOI":"10.1074\/jbc.M802475200","article-title":"Regulation of postsynaptic RapGAP SPAR by Polo-like kinase 2 and the SCFbeta-TRCP ubiquitin ligase in hippocampal neurons","volume":"283","author":"Ang","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e39571_bib131","doi-asserted-by":"crossref","first-page":"595","DOI":"10.15252\/emmm.201606210","article-title":"The amyloid hypothesis of Alzheimer's disease at 25 years","volume":"8","author":"Selkoe","year":"2016","journal-title":"EMBO Mol. Med."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e39571_bib132","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/s41392-023-01484-7","article-title":"Amyloid beta-based therapy for Alzheimer's disease: challenges, successes and future","volume":"8","author":"Zhang","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"9","key":"10.1016\/j.heliyon.2024.e39571_bib133","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/aps.2017.28","article-title":"Amyloid beta: structure, biology and structure-based therapeutic development","volume":"38","author":"Chen","year":"2017","journal-title":"Acta Pharmacol. Sin."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e39571_bib134","doi-asserted-by":"crossref","DOI":"10.3390\/biom13020313","article-title":"The amyloid-beta clearance: from molecular targets to glial and neural cells","volume":"13","author":"Cai","year":"2023","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e39571_bib135","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13073-023-01155-w","article-title":"The neuroimmune axis of Alzheimer's disease","volume":"15","author":"Jorfi","year":"2023","journal-title":"Genome Med."},{"key":"10.1016\/j.heliyon.2024.e39571_bib136","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.arr.2017.08.005","article-title":"The role of the immune system in Alzheimer disease: etiology and treatment","volume":"40","author":"Jevtic","year":"2017","journal-title":"Ageing Res. Rev."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e39571_bib137","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8050651","article-title":"Vascular dysfunction in Alzheimer's disease: a prelude to the pathological process or a consequence of it?","volume":"8","author":"Govindpani","year":"2019","journal-title":"J. Clin. Med."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024156022?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024156022?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T10:24:37Z","timestamp":1775730277000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844024156022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":137,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S2405844024156022"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e39571","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacological inhibition of PLK2 kinase activity mitigates cognitive decline but aggravates APP pathology in a sex-dependent manner in APP\/PS1 mouse model of Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e39571","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e39571"}}